Ramky Infrastructure Ltd’s subsidiary MILeS City has entered into a concession agreement with MIDC to develop a ₹30 billion pharma park in Raigad, Maharashtra. The project will be built under a PPP model with a 95-year concession period, aiming to boost India’s pharmaceutical manufacturing and life sciences ecosystem.
Introduction To The Announcement
On March 13, 2026, Ramky Infrastructure Ltd announced that its wholly owned subsidiary MILeS City signed a concession agreement with MIDC for the development of a high-tech pharmaceutical park at the Dighi Port Industrial Area in Raigad district, Maharashtra.
Project Details
-
Project value: ₹30 billion (₹3,000 crore)
-
Location: Dighi Port Industrial Area, Raigad district, Maharashtra
-
Model: Public-Private Partnership (PPP) under DBFOT (Design, Build, Finance, Operate, Transfer)
-
Concession period: 95 years, including a five-year construction phase
Strategic Importance
The pharma park will serve as a hub for pharmaceutical manufacturing, research, and life sciences innovation. It is expected to attract global investments, create jobs, and strengthen India’s position as a leading pharmaceutical exporter.
Broader Implications
This project underscores the government’s push to enhance industrial infrastructure and promote healthcare innovation. For Ramky Infrastructure, it represents a landmark opportunity to expand into life sciences and establish long-term revenue streams.
Key Highlights
• Ramky Infrastructure subsidiary MILeS City signs concession agreement with MIDC
• ₹30 billion pharma park to be developed in Raigad, Maharashtra
• Executed under PPP framework with DBFOT model
• 95-year concession period including five-year construction phase
• Project to boost pharma manufacturing and life sciences innovation
Sources: Free Press Journal, TechTeam News, MIDC Corporate Release